Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Bioxytran, Inc.(BIXT) the EBIT is -660.18 K (-191.4%);the EPS is -0.0054 (-1462%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B191.36%
----
----
EPS
-0.00541462.06%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf